Dysregulation of critical genes (such as ACACA, FASN, and CPT1A) in fatty acid metabolism, leading to an imbalance in fatty acid degradation and production, was considered as a potential metabolic marker for cancer cells (35). The gene discussed is CPT1A; the disease is cancer.